Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Return on Sales (2024 - 2025)

Incannex Healthcare (IXHL) has disclosed Return on Sales for 2 consecutive years, with 1304.2% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 81303.0% to 1304.2% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4849.9% through Dec 2025, down 457343.0% year-over-year, with the annual reading at 545.17% for FY2025, 99308.0% up from the prior year.
  • Return on Sales hit 1304.2% in Q4 2025 for Incannex Healthcare, down from 1281.4% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 73.24% in Q3 2024 to a low of 1304.2% in Q4 2025.